An analysis of nearly 10,000 people taking semaglutide drugs found they lost on average 10.2-13.2% of baseline weight over 12 months.(8) Its important to note that GLP-1 clinical trials employ run-in periods where non-adherent participants are excluded.(9) Real world patients face many barriers to consistent adherence, including side effects, injection anxieties, medication costs and behavioral challenges
It decreases total energy intake by reducing cravings for energy-dense, highly palatable foods
To administer Tirzepatide, one should follow the step by step instructions provided with the pen
Risks, Side Effects, and Safety Monitoring Post-Surgery Key risks include seizures, elevated blood pressure, opioid receptor blockade, CYP2D6 drug interactions, and worsening nutritional deficiencies
None of this reflects poor discipline